Barings LLC Has $2,592,000 Position in Acadia Healthcare Company, Inc. (ACHC)
Barings LLC continued to hold its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the second quarter, according to the company in its most recent filing with the SEC. The firm owned 59,455 shares of the company’s stock at the close of the second quarter. Barings LLC owned approximately 0.07% of Acadia Healthcare worth $2,592,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of ACHC. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after buying an additional 270 shares during the last quarter. Riverhead Capital Management LLC acquired a new position in Acadia Healthcare during the second quarter worth $209,000. Paloma Partners Management Co acquired a new position in Acadia Healthcare during the first quarter worth $217,000. M&T Bank Corp acquired a new position in Acadia Healthcare during the first quarter worth $230,000. Finally, World Asset Management Inc acquired a new position in Acadia Healthcare during the second quarter worth $242,000.
Shares of Acadia Healthcare Company, Inc. (ACHC) opened at 45.63 on Friday. The stock has a 50 day moving average of $46.66 and a 200-day moving average of $46.25. The company has a market cap of $4.01 billion, a PE ratio of 501.43 and a beta of 1.07. Acadia Healthcare Company, Inc. has a 12 month low of $32.54 and a 12 month high of $54.34.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $715.90 million during the quarter, compared to analyst estimates of $717.38 million. During the same quarter last year, the firm posted $0.73 EPS. The firm’s revenue for the quarter was down 5.4% on a year-over-year basis. Equities analysts forecast that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.
A number of brokerages recently weighed in on ACHC. Mizuho boosted their target price on shares of Acadia Healthcare from $57.00 to $60.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Zacks Investment Research downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, October 2nd. BidaskClub upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, June 10th. Craig Hallum reiterated a “buy” rating and issued a $65.00 price objective (up from $52.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Finally, Deutsche Bank AG upped their price objective on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a report on Monday, July 31st. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $56.90.
TRADEMARK VIOLATION NOTICE: “Barings LLC Has $2,592,000 Position in Acadia Healthcare Company, Inc. (ACHC)” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/barings-llc-has-2592000-position-in-acadia-healthcare-company-inc-achc/1615110.html.
In related news, CEO Joey A. Jacobs sold 500,000 shares of Acadia Healthcare stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $25,345,000.00. Following the completion of the sale, the chief executive officer now owns 201,496 shares of the company’s stock, valued at approximately $10,213,832.24. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director William Grieco sold 2,000 shares of Acadia Healthcare stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $51.71, for a total value of $103,420.00. Following the completion of the sale, the director now directly owns 45,013 shares of the company’s stock, valued at approximately $2,327,622.23. The disclosure for this sale can be found here. In the last three months, insiders sold 3,085,693 shares of company stock valued at $157,729,099. 11.10% of the stock is currently owned by insiders.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.